Movement Disorders - Parkinson’s Disease

The Movement Disorders Division within the Yale Department of Neurology comprises physicians and scientists dedicated to the recognition, evaluation, treatment, and understanding of the full range of movement disorders. The Yale Movement Disorders Clinic provides consultations and care for patients with Parkinson's disease and related illnesses, tremor disorders, Huntington’s disease and other choreas, dystonias, tic disorders, myoclonus and other movement disorders either caused by primary nervous system dysfunction or secondary to medical illnesses and medications including tardive dyskinesias. The group has a special interest in primary and secondary ataxias, gait disorders, restless legs syndrome and stiff-person syndrome. The physician specialists also provide in-patient consultation to physicians at Yale–New Haven Hospital for the aforementioned movement disorders.

The treatment strategies include application of state of the art medications for treatment of Parkinson’s disease and other movement disorders. The program also includes use of botulinum toxins for treatment of a variety of movement disorders, spasticity (secondary to stroke, multiple sclerosis, cerebral palsy or trauma), and pain.

Within the Yale Movement Disorders Division is the Deep Brain Stimulation (DBS) Clinic, which provides patient screening before DBS surgery for refractory symptoms of Parkinson’s disease, essential tremor and dystonias. During this clinic the movement disorder specialists work closely with the stereotactic neurosurgeons at Yale in preparation for DBS surgery and conduct DBS device programming and adjustments after surgery.

The Yale Movement Disorders Clinic is multidisciplinary and collaborates with clinicians and researchers associated with Yale Stereotactic and Functional Neurosurgery, Yale Neuropsychology, and Yale Neurogenetics. We have several ongoing clinical research studies, and all patients have the option to participate in one or more clinical trials. We are also an active teaching clinic and provide ongoing education in the area of Parkinson’s disease and movement disorders to medical students, neurology and medical residents, and visiting physicians. We also have a fellowship program and train fellows in all aspects of movement disorders.

Louis, Elan D

Chief, Movement Disorders

Chief, Division of Movement Disorders
Professor of Neurology

Jabbari, Bahman

Professor of Neurology
Director, Botulinum Toxin treatment program

Machado, Duarte Goncalves

Assistant Professor of Neurology
Lead Neurologist, Yale Health Center

Salardini, Arash

Clinical Fellow in and Instructor in Neurology


Call  (203) 737-5259 or (203) 785-4085to schedule an appointment or make a referral to the Yale Movement Disorders Clinic.

    Parkinson’s Disease

    Patients with Parkinson’s Disease and related neurodegenerative disorders get cutting-edge treatment at Yale neurology’s Movement Disorders clinic. Three attending physicians coordinate care, clinical trial enrollment, botulinum toxin injections, and education of rotating fellows, residents, and students. 

    The Movement Disorder Division is focused on the discovery of new drugs for better management of symptoms of Parkinson’s disease and other movement disorders. Research studies are both multi-center (national and international) or single center conducted at Yale University. All human studies are approved by the Yale Human Investigation Committee. The Movement Disorder Division also conducts research studies on the efficacy and safety of botulinum toxins in movement disorders and pain. Other research protocols pertain to the study of different symptoms in Parkinson’s disease and the application of modern neuroimaging such as fMRI and MR spectroscopy in order to discern the pathophysiology of movement disorders. The movement disorder specialists also collaborate with researchers in the Institute of Neurodegenerative Disorders (60 Temple St) and refer patients for research studies in that Institute.

    Division of Movement Disorders Active Research Trials
    • Studies To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
    • Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches





    Yale Physician's Building
    800 Howard Avenue, Lower Level
    New Haven, CT 06510

    Our clinics are located at the Yale Physician's Building, 800 Howard Avenue, Lower Level, New Haven CT. Patients are scheduled between 8am to 4:30pm.

    Postal inquiries can be sent to:

    Yale Neurology Clinics
    Yale Physician's Building
    800 Howard Avenue, Lower Level
    New Haven, CT 06510